Manuscripts

Search by keyword, year, or author name.

Showing 1602 manuscripts.

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV

Grace McComsey, M.D., Michelle A. Kendall, M.S., Pablo Tebas, M.D., Susan Swindells, M.B.B.S., Evelyn Hogg, B.A., Beverly L. Alston-Smith, M.D., Carol Suckow, B.S.N., Geetha Gopalakrishnan, M.D., Constance A. Benson, M.D., David Alain Wohl, M.D. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS. 2007 Nov 30; 21(18):2473-82.

Year

2007

Journal

AIDS

Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384

Michael P. Dube, M.D., Robert A. Parker, Sc.D., Kathleen Mulligan, Ph.D., Pablo Tebas, M.D., Gregory K. Robbins, M.D., M.P.H., Ronenn Roubenoff, M.D., M.H.S., Steven K. Grinspoon, M.D. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384. Clinical Infectious Diseases. 2007 Jul 01; 45(1):120-6. PMID: 17554712.

Year

2007

Journal

Clinical Infectious Diseases

Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations

B. Healy, Victor DeGruttola, Sc.D., Marcello Pagano. Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations. Biometrics. 2007 Sep 01; 63(3):742-50.

Year

2007

Journal

Biometrics

Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase

Zixin Hu, Ph.D., Hiroyu Hatano, M.D., M.H.S., Scott Hammond, Danielle Smith, B.S., Mary Wild, R.N., Soumi Gupta, Ph.D., Jeannette M. Whitcomb, Robert C Kalayjian, M.D., Barbara Gripshover, M.D., Daniel R. Kuritzkes, M.D. Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. Journal of Acquired Immune Deficiency Syndromes. 2007 Aug 15; 45(5):494-500. PMID: 17496561.

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes

Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection

J. William Critchfield, Donna Lemongello, Digna H. Walker, Juan C. Garcia, David M. Asmuth, M.D., Richard B. Pollard, M.D., B. L. Shacklett. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. Virology. 2007 Jun 01; 81(11):5460-5471.

Year

2007

Journal

Virology

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial- AIDS Clinical Trials Group 328

Ronald T. Mitsuyasu, M.D., Rebecca S. Gelman, Ph.D., Richard B. Pollard, M.D., Deborah Weng-Cherng, M.S., Alan Landay, Ph.D., John L. Fahey, M.D., Richard C. Reichman, M.D., Alejo Erice, M.D., R. Pat Bucy, M.D., Ph.D., J. Michael Kilby, M.D., Michael M. Lederman, M.D., Carol S. Dukes-Hamilton, M.D., Juan J.L. Lertora, M.D., Ph.D., Becky Stephenson, M.D., Pablo Tebas, M.D., Anne-Marie Duliege, M.D., M.S., Richard B. Pollard, M.D. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial- AIDS Clinical Trials Group 328. Archives of Internal Medicine. 2007 Mar 26; 167(6):597-605. PMID: 17389292.

Year

2007

Journal

Archives of Internal Medicine